ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 162 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $29 | +123.1% | 18 | 0.0% | 0.00% | – |
| Q1 2023 | $13 | +30.0% | 18 | 0.0% | 0.00% | – |
| Q4 2022 | $10 | – | 18 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 18 | -100.0% | 0.00% | – |
| Q1 2022 | $62,000 | -33.3% | 47,178 | -10.6% | 0.00% | – |
| Q4 2021 | $93,000 | -13.9% | 52,776 | +5.6% | 0.00% | – |
| Q3 2021 | $108,000 | -94.2% | 49,988 | -90.6% | 0.00% | -100.0% |
| Q2 2021 | $1,866,000 | +161.7% | 532,930 | +636.0% | 0.00% | – |
| Q1 2021 | $713,000 | -26.3% | 72,413 | -18.8% | 0.00% | -100.0% |
| Q4 2020 | $967,000 | -91.0% | 89,223 | -91.4% | 0.00% | -85.7% |
| Q3 2020 | $10,721,000 | +1087.3% | 1,040,815 | +2306.3% | 0.01% | +600.0% |
| Q2 2020 | $903,000 | -11.9% | 43,253 | -58.7% | 0.00% | 0.0% |
| Q1 2020 | $1,025,000 | -59.5% | 104,817 | -52.3% | 0.00% | -50.0% |
| Q4 2019 | $2,530,000 | +441.8% | 219,774 | +155.7% | 0.00% | – |
| Q3 2019 | $467,000 | +17.6% | 85,966 | +156.6% | 0.00% | – |
| Q2 2019 | $397,000 | +14.4% | 33,508 | -49.8% | 0.00% | – |
| Q1 2019 | $347,000 | -8.4% | 66,689 | -44.7% | 0.00% | – |
| Q4 2018 | $379,000 | -83.4% | 120,493 | -68.0% | 0.00% | -100.0% |
| Q3 2018 | $2,277,000 | -32.7% | 376,730 | -41.0% | 0.00% | 0.0% |
| Q2 2018 | $3,383,000 | +126.3% | 638,630 | +147.6% | 0.00% | 0.0% |
| Q1 2018 | $1,495,000 | +11.5% | 257,938 | -32.7% | 0.00% | 0.0% |
| Q4 2017 | $1,341,000 | +97.2% | 383,330 | +105.6% | 0.00% | – |
| Q3 2017 | $680,000 | +176.4% | 186,445 | +88.6% | 0.00% | – |
| Q2 2017 | $246,000 | -27.9% | 98,839 | -22.4% | 0.00% | – |
| Q1 2017 | $341,000 | +11.1% | 127,343 | +19.5% | 0.00% | – |
| Q4 2016 | $307,000 | -71.2% | 106,523 | -59.0% | 0.00% | -100.0% |
| Q3 2016 | $1,065,000 | +32.1% | 259,539 | +1.7% | 0.00% | 0.0% |
| Q2 2016 | $806,000 | – | 255,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |